← Back to Search

CONTINUUM Intervention for Cancer

N/A

Waitlist Available

Led By Jennifer S Temel, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 10-15 days after hospital discharge

Awards & highlights

Study Summary

This trial is testing whether a follow-up care intervention using video visits within three days of hospital discharge may improve care transitions for patients with advanced cancer.

Eligible Conditions

Cancer
Follow-up Care
Telemedicine

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 10-15 days after hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 10-15 days after hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 10-15 days after hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patients' Confidence in Managing their Health Condition using the Patient Activation Measure-13 (PAM-13)

Secondary outcome measures

Psychological Symptoms using the Patient Health Questionnaire-4 (PHQ-4)

Quality of Communication using the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Communication subscale

Symptom Burden using the Edmonton Symptom Assessment Scale (ESAS-r)

Other outcome measures

30-day Hospital Readmissions

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CONTINUUM Intervention Post-Hospital DischargeExperimental Treatment1 Intervention

Participants will receive CONTINUUM intervention visit with a nurse practitioner within three business days of hospital discharge and complete questionnaires about their cancer and care.

Group II: Usual Care Post-Hospital DischargeActive Control1 Intervention

Participants will receive standard oncology care following hospital discharge with follow-up appointments scheduled per primary team and participant preferences. Participants will complete questionnaires about their cancer and care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,929 Previous Clinical Trials

13,198,019 Total Patients Enrolled

Conquer Cancer FoundationOTHER

19 Previous Clinical Trials

3,689 Total Patients Enrolled

Jennifer S Temel, MDPrincipal InvestigatorMassachusetts General Hospital

2 Previous Clinical Trials

218 Total Patients Enrolled

Media Library

CONTINUUM Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05142345 — N/A

Cancer Research Study Groups: Usual Care Post-Hospital Discharge, CONTINUUM Intervention Post-Hospital Discharge

Cancer Clinical Trial 2023: CONTINUUM Intervention Highlights & Side Effects. Trial Name: NCT05142345 — N/A

CONTINUUM Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05142345 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the overall participation rate of this clinical research?

"Yes, clinicaltrials.gov data indicates that enrollment in this medical trial is ongoing and 286 participants are needed to be recruited from 1 study site. This research was initially posted on December 15th 2021 with the most recent update occuring February 10th 2022."

Answered by AI

Are there any openings still available for individuals to take part in this investigation?

"Yes, evidence on clinicaltrials.gov indicates that this medical trial is actively seeking to enroll patients. The study was initially posted on December 15th 2021 and last updated February 10th 2022; it needs 286 participants from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Care Transition Intervention for Hospitalized Patients With Advanced Cancer

Jennifer Temel, MD 2021. "Care Transition Intervention for Hospitalized Patients With Advanced Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05142345.